Although tracking has been studied for decades, real-time tracking algorithms often suffer from low accuracy and poor robustness when confronted with difficult, real-world data.
Stanford researchers have created a device with defined parallel-oriented fibrillar nanostructure that can control endothelial cell alignment along the direction of the fibrillar nanostructure.
Stanford researchers have developed a system for precise genetic modification of human embryonic stem cells (ECSs) and induced pluripotent stem cells (iPSCs).
Researchers in Prof. Vijay Pande's laboratory developed a novel computational technique (“SCISSORS”) that affords several orders of magnitude acceleration in chemical library screening.
Stanford Researchers have patented an improved technique for capturing and processing dynamic and high speed scenes using a collection of precisely timed video cameras. This system uses multiple synchronized image sensors with precise time delays to capture high-speed video.
Researchers in the laboratory of Dr. Michael Cleary at Stanford University have developed anti-Pbx3b monoclonal antibodies to study transcriptional regulation and embryonic development.
Researchers in the laboratory of Dr. Michael Cleary at Stanford University have developed anti-Pknox monoclonal antibodies to study transcriptional regulation, embryonic development, and tissue homeostasis.
Researchers in the laboratory of Dr. Michael Cleary at Stanford University have developed anti-Set1p monoclonal antibodies to study chromatin regulation and histone methylation.
Researchers in the laboratory of Dr. Michael Cleary at Stanford University have developed anti-Pbx1a monoclonal antibodies to study transcriptional regulation, embryonic development, and tissue homeostasis.
Researchers in the laboratory of Dr. Michael Cleary at Stanford University have developed anti-Pbx3a monoclonal antibodies to study transcriptional regulation and embryonic development.
A team of researchers from the Stanford Artificial Intelligence Laboratory have patented a portfolio of innovations that harness depth sensing technology to analyze human motion for touch-free control of devices and motion capture.
Soluble CD81 molecules were constructed for the purpose of identifying a postulated ligand to CD81. Recently CD81 has been claimed by others to be a candidate for a receptor for the human hepatitis C virus (HCV).